Manifold Partners’s iShares Biotechnology ETF IBB Stock Holding History

Manifold Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-63,678	Closed	-$7.08M	–	19
2017 Q3	$7.08M	Buy	63,678 +5,916	+10%	+$632K	5.58%	8
2017 Q2	$5.97M	Buy	57,762 +1,098	+2%	+$108K	6.98%	7
2017 Q1	$5.54M	Buy	+56,664	New	+$5.42M	5.05%	10
2014 Q1	–	Sell	-5,142	Closed	-$389K	–	79
2013 Q4	$389K	Buy	+5,142	New	+$365K	0.25%	56

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Manifold Partners's IBB Position: Q4 2017 in Review

Manifold Partners sold out of iShares Biotechnology ETF (IBB) in Q4 2017, closing a stake of 63,678 shares — an estimated $7.08M sold.

Manifold Partners first reported a position in IBB in Q4 2013 and held it in 4 quarters. The position peaked at $7.08M in Q3 2017. 624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

Manifold Partners reported no remaining iShares Biotechnology ETF position as of Q4 2017 after selling out during the quarter.
Manifold Partners sold 63,678 iShares Biotechnology ETF shares in Q4 2017, an estimated $7.08M.
Manifold Partners first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 4 quarters.
Manifold Partners's iShares Biotechnology ETF position peaked at $7.08M in Q3 2017.
624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on Manifold Partners's 13F filing for Q4 2017, filed 12 Feb 2018.